253 related articles for article (PubMed ID: 2547935)
21. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.
Nakazawa T; Yamanishi Y; Kaneko T
J Pharmacol Exp Ther; 1991 May; 257(2):748-53. PubMed ID: 1674534
[TBL] [Abstract][Full Text] [Related]
23. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid.
Vonvoigtlander PF; Lewis RA
J Pharmacol Exp Ther; 1988 Jul; 246(1):259-62. PubMed ID: 2839665
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
25. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
Craft RM; Dykstra LA
J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
[TBL] [Abstract][Full Text] [Related]
26. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
27. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy.
Hiramatsu M; Hoshino T
Brain Res; 2004 Dec; 1030(2):247-55. PubMed ID: 15571673
[TBL] [Abstract][Full Text] [Related]
28. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
[TBL] [Abstract][Full Text] [Related]
29. Further study of kappa opioids on increased urination.
Leander JD
J Pharmacol Exp Ther; 1983 Oct; 227(1):35-41. PubMed ID: 6137557
[TBL] [Abstract][Full Text] [Related]
30. Antagonism of kappa opioid mediated effects in the rat by cyclo(Leu-Gly).
Bhargava HN; Ramarao P
Life Sci; 1989; 45(26):2521-8. PubMed ID: 2559273
[TBL] [Abstract][Full Text] [Related]
31. Spinal involvement of both dynorphin A and Met-enkephalin in the antinociception induced by intracerebroventricularly administered bremazocine but not morphine in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1993 Sep; 266(3):1430-8. PubMed ID: 8103794
[TBL] [Abstract][Full Text] [Related]
32. Differential cross-tolerance to opioid agonists in morphine-tolerant pigeons responding under a schedule of food presentation.
Craft RM; Picker MJ; Dykstra LA
J Pharmacol Exp Ther; 1989 May; 249(2):386-93. PubMed ID: 2542528
[TBL] [Abstract][Full Text] [Related]
33. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
34. Indirect involvement of delta opioid receptors in cholecystokinin octapeptide-induced analgesia in mice.
Hong EK; Takemori AE
J Pharmacol Exp Ther; 1989 Nov; 251(2):594-8. PubMed ID: 2553928
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of the antinociceptive action of the selective kappa-opioid receptor agonist, U-50,488H by ICS-205-930.
Ho BY; Takemori AE
Eur J Pharmacol; 1990 Mar; 178(3):371-3. PubMed ID: 2160372
[TBL] [Abstract][Full Text] [Related]
36. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
[TBL] [Abstract][Full Text] [Related]
37. Dynorphin prolongs the action potential of mouse sensory ganglion neurons by decreasing a potassium conductance whereas another specific kappa opioid does so by increasing a calcium conductance.
Shen KF; Crain SM
Neuropharmacology; 1990 Apr; 29(4):343-9. PubMed ID: 1971431
[TBL] [Abstract][Full Text] [Related]
38. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
Yamamoto T; Ohno M; Ueki S
Eur J Pharmacol; 1988 Oct; 156(1):173-6. PubMed ID: 2850208
[TBL] [Abstract][Full Text] [Related]
39. Effects of acute and chronic administration of dizocilpine on the pharmacological responses to U-50,488H and brain and spinal cord kappa-opioid receptors in the rat.
Bhargava HN; Matwyshyn GA; Gudehithlu KP
Pharmacology; 1995 Nov; 51(5):323-30. PubMed ID: 8584584
[TBL] [Abstract][Full Text] [Related]
40. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
Bhargava HN; Gulati A; Ramarao P
Pharmacology; 1991; 42(3):121-7. PubMed ID: 1647533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
